Records containing: Lung Cancer, Nonsmall Cell
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-03-29A Prospective, Randomized Clinical Study of the Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) With Thalidomide
-
CLINICAL_TRIALS study record update · 2024-03-20Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung Tumors Using Real-Time Tumor Tracking & Respiratory Gating: A Seamless Phase I/II Prospective Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-03-20High-dose Furmonertinib Versus Osimertinib as First-line Treatment in Advanced EGFR Mutation-positive NSCLC Patients With Brain Metastases: a Multi-center, Randomized, Controlled, Prospective, Phase II Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-03-07A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Utilising a Novel Multi-arm Frequency-response Optimisation Design
-
CLINICAL_TRIALS study record update · 2024-03-05Feasibility Study of Lung Cancer Screening in the Flemish Region, the ZORALCS Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-22Clinical Trials on Detection of Lung Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC and T Cells
-
CLINICAL_TRIALS study record update · 2023-09-29Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Self-Management and Wellness for Survivors of Lung Cancer and Their Family Members
-
CLINICAL_TRIALS study record update · 2023-07-03Move For Surgery - A Novel Preconditioning Program to Optimize Health Before Thoracic Surgery: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-06-22Clinical Study of Plasmodium Immunotherapy for Advanced Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2023-06-01Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity
-
CLINICAL_TRIALS study record update · 2023-02-13Multiparameter Prediction Model of Immune Checkpoint Inhibitors Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer: a Real-world Study
-
CLINICAL_TRIALS study record update · 2023-01-06I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
-
CLINICAL_TRIALS study record update · 2022-12-06Screening Protocol to Assess the Expression of Tumor Associated Antigens (TAAs), Human Papillomavirus (HPV-16) Antigens and Human Leucocyte Antigen (HLA) Sub-Types in Patients With Head and Neck, Cervical, Melanoma and Non-Small Cell Lung Cancers.
-
CLINICAL_TRIALS study record update · 2022-07-25Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy: A Prospective, Randomized, Placebo-controlled Single Center Trial
-
CLINICAL_TRIALS study record update · 2022-05-09FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
-
CLINICAL_TRIALS study record update · 2022-04-06Effect Of Exercise Training In Patients With Lung Cancer During Chemotherapy Treatment
-
CLINICAL_TRIALS study record update · 2022-02-11A Phase II Trial to Evaluate Crizotinib in the Neoadjuvant Setting in Patients With Surgically Resectable, ALK, ROS1, or MET-oncogene Positive Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2021-11-04A Multi-center, Open-label Trial Investigating the Efficacy and Safety of Continued Treatment With Tisotumab Vedotin in Patients With Solid Tumors Known to Express Tissue Factor.
-
CLINICAL_TRIALS study record update · 2021-09-17Perfusion and Functional Results After Pulmonary Artery Reconstruction During Oncologic Lung Resection
-
CLINICAL_TRIALS study record update · 2021-07-08A Phase I/II, Multi-center Clinical Study: Dose-finding Phase I Study of Foritinib Succinate in Advanced ALK-positive NSCLC Patients and Phase II Study of Foritinib Succinate in ALK or ROS1-positive NSCLC Patients
-
CLINICAL_TRIALS study record update · 2021-06-01The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung: a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2020-06-22Remote Monitoring of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment: a Feasibility Study
-
CLINICAL_TRIALS study record update · 2020-06-04Efficacy and Safety of X-396 (Ensartinib) in ALK-Positive NSCLC Patients With Brain Metastases: A Phase Ⅱ, Open-Label, Single Arm, Multicenter Study
-
CLINICAL_TRIALS study record update · 2020-05-01A Randomized Controlled Feasibility Study Looking at Differences in Hospital Stay Variables Following Omission of Daily Routine Chest Radiographs After Pulmonary Resection.
-
CLINICAL_TRIALS study record update · 2020-02-05Mutation Profile Detection, Therapeutic Resistance and Clonal Evolution Assessed With Liquid Biopsy of Advanced NSCLC Patients in China